XTrackers FTSE 100 Short Daily Swap UCITS ETF 1C
| Issuer: Xtrackers |
| Asset Class: Equity |
| TER: 50bps |
| Trading Currency: GBX |
| Pays Income: False |
| Listing Date: 17 Jun 2008 |
| Ticker: XUKS |
| ISIN: LU0328473581 |
This investment vehicle offers a strategic tool for investors seeking to take an inverse position on the UK's leading stock market index. It is specifically designed to provide the opposite return of the FTSE 100 index on a daily basis, before fees and expenses. If the index of the UK's top 100 blue-chip companies falls by a certain percentage on a given day, the value of this product is designed to rise by a corresponding percentage, and vice-versa. This makes it a potential instrument for those with a bearish outlook on the UK equity market in the short term, allowing them to profit from market downturns.
The product can be employed for two primary purposes: tactical speculation or strategic hedging. As a speculative tool, an investor might use it to act on a conviction that the UK market is overvalued or facing imminent headwinds, such as economic uncertainty, political instability, or changing monetary policy. As a hedging instrument, an investor with a substantial long portfolio of UK large-cap stocks could use this fund to offset potential short-term losses. By holding a position in this inverse product, they can mitigate the impact of a market decline on their overall portfolio value without having to sell their core holdings.
It is crucial for investors to understand the nature of daily rebalancing. The product aims to deliver the -1x return of its underlying index for a single day only. Over longer periods, the effects of compounding can cause the fund's performance to deviate significantly from the simple inverse of the index's cumulative performance. This phenomenon, known as compounding risk or path dependency, means the product is generally better suited for short-term tactical use rather than long-term, buy-and-hold strategies. Its synthetic, swap-based structure also introduces counterparty risk, although this is managed within the UCITS regulatory framework.
